Exigyn offers a cloud‑based financial planning and analysis platform built specifically for biotech companies. It provides modular, zero‑code tools for cash‑runway forecasting, headcount planning, clinical trial budgeting, and board reporting, with AI‑enhanced connectors for Excel and PowerPoint and multi‑entity consolidation features. The subscription service enables finance teams to create, compare, and present forecasts quickly, scaling from early‑stage startups to late‑stage enterprises.
Funding
Funding not disclosed
Founders
Product
Problem
Biotech companies often rely on fragmented spreadsheets and generic financial planning tools that require extensive setup, lack industry-specific models, and delay critical cash‑runway and trial budgeting decisions.
Solution
Exigyn provides a cloud‑based, biotech‑focused financial planning and analysis (FP&A) platform that streamlines cash‑runway forecasting, headcount planning, clinical trial budgeting, and board reporting. The system offers modular components that can be assembled in days rather than months, eliminating lengthy implementation projects. Built‑in scenario modeling and AI‑driven connectors for Excel and PowerPoint enable finance teams to create, compare, and present forecasts quickly. Multi‑entity consolidation and audit‑trail features support late‑stage organizations with complex structures. The platform is delivered as a subscription service with tiered pricing to match the needs of early‑stage, growth‑stage, and enterprise biotech firms.
Target Audience
Primary customers are finance teams at biotech companies ranging from Series A‑B startups to late‑stage, multi‑entity enterprises that need specialized FP&A tools.
Features
- Modular FP&A components (cash runway, headcount, trial budgets, etc.) selectable per company stage
- Zero‑code implementation; ready-to‑use templates launch in days
- AI‑enhanced connectors for seamless data exchange with Excel and PowerPoint
- Scenario modeling with unlimited users and real‑time collaboration
- Multi‑entity consolidation, scenario comparison, and audit‑trail capabilities for late‑stage organizations
- Export-ready board decks and customizable reporting dashboards
- Embedded advisory option with finance experts for strategic partnership